0001019056-16-001465.txt : 20160805 0001019056-16-001465.hdr.sgml : 20160805 20160805203429 ACCESSION NUMBER: 0001019056-16-001465 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160803 FILED AS OF DATE: 20160805 DATE AS OF CHANGE: 20160805 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aptevo Therapeutics Inc. CENTRAL INDEX KEY: 0001671584 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811567056 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-838-0500 MAIL ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stromatt Scott C CENTRAL INDEX KEY: 0001679975 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37746 FILM NUMBER: 161812358 MAIL ADDRESS: STREET 1: 2401 4TH AVENUE STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 stromatt_4.xml OWNERSHIP DOCUMENT X0306 4 2016-08-03 0 0001671584 Aptevo Therapeutics Inc. APVO 0001679975 Stromatt Scott C 2401 4TH AVENUE, SUITE 1050 SEATTLE WA 98121 0 1 0 0 Chief Medical Officer and SVP Common Stock 8412 D Restricted Stock Unit 2016-08-03 4 A 0 54762 0 A Common Stock 54762 54762 D Restricted Stock Unit 2016-08-03 4 A 0 78124 0 A Common Stock 78124 78124 D Shares received in a pro rata distribution by Emergent BioSolutions Inc. ("Emergent") as a result of the spin-off of the Issuer from Emergent, effective on August 1, 2016. Each restricted stock unit represents the right of Mr. Stromatt to receive one share of common stock of the Issuer. The restricted stock units were granted on August 3, 2016 and will vest as follows: (i) 27,381 on January 31, 2017 and (ii) 27,381 on January 31, 2018. The restricted stock units were granted on August 3, 2016 and will vest on July 29, 2017. /s/ Carl A. Valenstein, attorney-in-fact 2016-08-05